Suppr超能文献

基于川芎茶调方散剂与丸剂生物药剂学性质探讨中成药“同方不同剂型”现象的科学合理性

Exploring the Scientific Rationality of the Phenomenon of "Different Dosage Forms of the Same Prescription" of Chinese Proprietary Medicine Based on Biopharmaceutical Properties of Powder and Pill of Chuanxiong Chatiao Prescription.

作者信息

Qu Zhong-Huan, Liu Lin, Zhang Xiao-Fei, Guo Dong-Yan, Zhai Bing-Tao, Zou Jun-Bo, Shi Ya-Jun

机构信息

Pharmacy College, Shaanxi University of Chinese Medicine, Xianyang, China.

Shangluo Hospital of Traditional Chinese Medicine, Shangluo, China.

出版信息

Front Pharmacol. 2022 Jun 9;13:893552. doi: 10.3389/fphar.2022.893552. eCollection 2022.

Abstract

The 2020 edition of the Pharmacopoeia of the People's Republic of China (Chinese Pharmacopoeia 2020 edition) has 255 Chinese prescriptions with different dosage forms, accounting for 21.09% of the total prescriptions (1,209) in Chinese Pharmacopoeia 2020 edition. However, the scientific rationality of the phenomenon of "Different Dosage Forms of the Same Prescription" of Chinese proprietary medicine has been less explored. Based on the dosage form theory of "components in pills release slowly and take effect in slow-acting manner, while in powders release quickly and take effect in fast-acting way," we provided the dissolution experiment and pharmacokinetics of Chuanxiong Chatiao powders and pills in order to rationalize the phenomenon of "Different Dosage Forms of the Same Prescription" of Chuanxiong Chatiao prescription. Chuanxiong Chatiao powders and pills were prepared in the laboratory referring to the preparation methods in the Chinese Pharmacopoeia 2020 edition, and the contents of tetramethylpyrazine, ferulic acid, nodakenin, and isoimperatorin were determined by the external standard method. We measured the dissolution of four analytes of Chuanxiong Chatiao powders and pills according to the second method for dissolution determination (paddle method) in the Chinese Pharmacopoeia 2020 edition, and their corresponding contents in each sampling point were determined by LC-MS/MS. We also provided a pharmacokinetic study of Chuanxiong Chatiao powders and pills. Six female domestic rabbits were divided into two groups (powder and pill groups) and given Chuanxiong Chatiao powders and pills (9.85 g/kg) by surgical administration separately. Blood samples were collected at 5, 15, 30, 45, 60, 90, 120, 150, 180, 240, 360, 480, 720, and 1,440 min after drug administration to measure the plasma concentration of the four analytes by LC-MS/MS. The results of dissolution experiment showed that the dissolution rate of four analytes in the powder group was greater than that of the pill group. However, the solubilities of tetramethylpyrazine and isoimperatorin were very low in the powder and pill, which may be related to their low solubility properties. The results of the pharmacokinetic study of Chuanxiong Chatiao powders and pills showed that (h) of ferulic acid and nodakenin in the powder group was 0.420 and 0.053 times that of the pill group and (h) of ferulic acid, nodakenin, and isoimperatorin of the powder group was 0.910, 0.262, and 0.661 times that of the pill group, respectively. The dissolution rate and pharmacokinetic parameters of four analytes in CXCTF could partly explain the scientific rationality of the classic theory of ", " as in Chinese, which is helpful for providing a basis for the comparison of subsequent dosage forms. The results of our studies also suggest the complexity of the design of dosage forms of Chinese proprietary medicines and imply that we should pay more attention to the scientific rationality of the phenomenon of "Different Dosage Forms of the Same Prescription."

摘要

《中华人民共和国药典》2020年版(《中国药典》2020年版)中有255种不同剂型的中药处方,占《中国药典》2020年版总处方数(1209种)的21.09%。然而,中成药“同方不同剂型”现象的科学合理性鲜有探讨。基于“丸剂成分释放缓慢、起效慢,散剂释放快、起效快”的剂型理论,我们进行了川芎茶调散和丸剂的溶出实验及药代动力学研究,以阐明川芎茶调方“同方不同剂型”现象的合理性。参照《中国药典》2020年版的制备方法在实验室制备川芎茶调散和丸剂,采用外标法测定川芎嗪、阿魏酸、川续断皂苷乙和异欧前胡素的含量。按照《中国药典》2020年版溶出度测定第二法(桨法)测定川芎茶调散和丸剂中4种分析物的溶出度,各取样点的相应含量采用液相色谱 - 串联质谱法测定。我们还进行了川芎茶调散和丸剂的药代动力学研究。将6只雌性家兔分为两组(散剂组和丸剂组),分别通过灌胃给予川芎茶调散和丸剂(9.85 g/kg)。给药后5、15、30、45、60、90、120、150、180、240、360、480、720和1440分钟采集血样,采用液相色谱 - 串联质谱法测定4种分析物的血浆浓度。溶出实验结果表明,散剂组4种分析物的溶出速率大于丸剂组。然而,川芎嗪和异欧前胡素在散剂和丸剂中的溶解度非常低,这可能与其低溶解性有关。川芎茶调散和丸剂的药代动力学研究结果表明,散剂组阿魏酸和川续断皂苷乙的t1/2分别为丸剂组的0.420倍和0.053倍,散剂组阿魏酸、川续断皂苷乙和异欧前胡素的AUC0 - t分别为丸剂组的0.910倍、0.262倍和0.661倍。川芎茶调方中4种分析物的溶出速率和药代动力学参数可部分解释中医“丸者缓也,散者速也”经典理论的科学合理性,有助于为后续剂型比较提供依据。我们的研究结果还提示了中成药剂型设计的复杂性,意味着我们应更加关注“同方不同剂型”现象的科学合理性。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8f89/9218571/693540ccd216/fphar-13-893552-g001.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验